Foghorn Therapeutics is a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression. These medicines are designed to modulate the chromatin regulatory system, which ...
Lead formulation and drug delivery technology development at Foghorn Therapeutics to advance complex injectable and oral products from preclinical to clinical stages.